Pedro Lins Palmeira Filho

Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ.

Alinea Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new therapeutics for the treatment of diabetes and metabolic disorders. The company was founded in August 2005 and is headquartered in Cambridge, MA.

WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

Part of BASF SE, Knoll AG Schweiz is a Swiss company that manufactures and markets health care, nutritional, and agricultural products. The company is based in Liestal, Switzerland.

Novonor engages in infrastructure and energy solutions. Its services include engineering and construction, industry, development and operation of infrastructure and energy projects, creating integrated and innovative solutions that serve both its clients and its communities. The company was founded in 1981and is headquartered in Salvador, Brazil.

Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI.

Odyssey Thera, Inc. operates as a biopharmaceutical company. The company was founded by John Westwick and Stephen W. Michnick in 2000 and is headquartered in San Ramon, CA.

Part of Opthea Ltd., Vegenics Pty Ltd. is an Australian company that provides medical research, development, and commercialization of biologic drugs. Vegenics was acquired by Opthea Ltd. on August 14, 2008 for $5.06 million.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA.

Ocyan Participações SA engages in the provision of oil and gas exploration, drilling, and extraction services. Its services include offshore drilling, pipe laying services, installment and manufacturing of subsea equipment, and offshore maintenance and services. The company was founded on November 7, 2006 and is headquartered in Rio de Janeiro, Brazil.

Part of Cancer Research Institute, Cancer Vaccine Acceleration Co. LLC is an alternative investment manager. The company is based in New York, NY.

AliveCor, Inc. develops mobile heart monitoring system. It offers kardia mobile that provides people with suspected or diagnosed heart conditions, and those at risk of heart conditions. The company was founded by David E. Albert, Bruce Satchwell, and Kim Barnett and is headquartered in San Francisco, CA.

iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.

Mendelics Análise Genômica SA is the first and largest laboratory in Latin America focused on genomic analysis. The company is based in São Paulo, Brazil and was founded by André Castilho Valim, João Paulo Fumio Whitaker Kitajima, Dave Schlesinger. Mendelics offers a range of genetic tests for hereditary cancer and has a program to support the diagnosis of patients with neurodevelopmental disorders and movement disorders in early childhood. Customers can contact the Brazilian company to schedule an exam or ask any questions about their exams, collection kits, or appointments.

Biomark Capital Management Co. LLC (Biomark Capital) is a private equity and venture capital firm founded in 2011 by David S. Wetherell. The firm is headquartered in Greenwich, Connecticut.

I2Dx, Inc. Develops diagnostic platform for the assessment of prodromal Alzheimer’s disease. The company was founded by Janos Redei and is headquartered in Palo Alto, CA.

iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom.

FinHealth Gestão de Recursos SA (FinHealth) an independent private equity and venture capital firm headquartered in Rio de Janeiro, Brazil. It was founded in 2010.

Timpel SA develops diagnostic tools for physicians to make decisions at the bedside. The company is based in São Paulo, Brazil. The Brazilian company was founded in 2004. The CEO is Rafael Holzhacker.

GF Participações SA is a company based in Rio de Janeiro, Brazil. The Brazilian company provides Placi - Cuidados Extensivos, which is a service related to extended care.

Pannex Therapeutics, Inc. operates as a biopharmaceutical company. The company is based in New York, NY. The company was founded by Thomas Gerlach, Gerhard Gross, David Bravo. David Bravo has been the CEO since incorporation.